Geography axis: coverage anchored in the United States. Pair with exactly one subject category (Pharma, Policy & Markets, Digital Health, Medical Devices or a Therapy Area). Company, regulator and payer go in tags.
A definitive merger agreement between Sutter Health and Allina Health would create an 88,000-employee nonprofit system with a $2B-plus investment commitment in Minnesota and Wisconsin.
Vepdegestrant’s May 1 approval for ESR1-mutant advanced breast cancer marks the first PROTAC-class drug cleared by the FDA, with VERITAC-2 trial data showing a hazard ratio of 0.70 over fulvestrant.
You must be logged in to post a comment.